发明授权
- 专利标题： Chemokine receptor binding compounds
- 专利标题（中）： 趋化因子受体结合化合物
-
申请号： US11453221申请日： 2006-06-14
-
公开(公告)号： US07790747B2公开(公告)日： 2010-09-07
- 发明人: Yuanxi Zhou , Elyse Bourque , Yongbao Zhu , Jonathan Langille , Markus Metz , Wen Yang , Ernest J. McEachern , Curtis Harwig , Ian R. Baird , Tong-Shuang Li , Renato T. Skerlj
- 申请人： Yuanxi Zhou , Elyse Bourque , Yongbao Zhu , Jonathan Langille , Markus Metz , Wen Yang , Ernest J. McEachern , Curtis Harwig , Ian R. Baird , Tong-Shuang Li , Renato T. Skerlj
- 申请人地址： US MA Cambridge
- 专利权人： Genzyme Corporation
- 当前专利权人： Genzyme Corporation
- 当前专利权人地址： US MA Cambridge
- 代理机构： Morrison & Foerster LLP
- 主分类号： A61K31/4545
- IPC分类号： A61K31/4545 ; C07D409/14
摘要：
The present invention relates to chemokine receptor binding compounds, pharmaceutical compositions and their use. More specifically, the present invention relates to modulators of chemokine receptor activity, preferably modulators of CCR5. These compounds demonstrate protective effects against infection of target cells by a human immunodeficiency virus (HIV).
公开/授权文献
- US20090099205A1 Chemokine receptor binding compounds 公开/授权日：2009-04-16